Sustained release aminopyridine composition
US8663685B2 · kind B2 · utility
3Cited by
19References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2011 |
| Grant date | Mar 4, 2014 |
| Priority date | — |
| Expiry date | Aug 25, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.